Search filters

List of works by Per thor Straten

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

scientific article

A Potential Role of Indoleamine 2,3-Dioxygenase-Specific T cells in Leishmania Vaccination ⬇️

scientific article published on July 8, 2011

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

scientific article published on 7 December 2008

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

scientific article (publication date: 16 July 2015)

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

scientific article

Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 19 December 2018

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

scientific article

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

scientific article published on November 2012

Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs

scientific article

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

scientific article published on July 2012

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

scientific article published on December 2012

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

scientific article published on 24 March 2011

Broadening the repertoire of melanoma-associated T-cell epitopes.

scientific article published on 18 February 2015

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

scientific article published on 17 February 2009

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation

scientific article

Cancer treatment: the combination of vaccination with other therapies

scientific article published on 20 February 2008

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

scientific article published on 01 March 2011

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

scientific article published on 26 April 2012

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

scientific article published on 18 June 2011

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes

scientific article published on November 2004

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

scientific article published on 18 April 2018

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

scientific article published on 26 September 2013

Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells.

scientific article published on 4 November 2015

Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".

scientific article published in November 2009

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

scientific article published on 29 November 2012

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

scientific article published on 2 August 2014

Cytotoxic T cells

scientific article

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

scientific article

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

scientific article published on 01 June 2015

Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report

scientific article published on 01 April 2002

Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers.

scientific article published on 7 November 2013

Dissection of T-cell Antigen Specificity in Human Melanoma

scientific article published on 06 February 2012

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

scientific article published on December 2003

Effector CD4 and CD8 T cells and their role in the tumor microenvironment

scientific article published on 16 December 2012

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient.

scientific article

Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark

scientific article published on 5 February 2012

Exercise and cancer: from "healthy" to "therapeutic"?

scientific article published on 21 March 2017

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells.

scientific article published on 4 November 2015

Exercise: A new role for an old tool.

scientific article published on 15 April 2016

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

scientific article published on 28 August 2020

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.

scientific article published on 24 September 2014

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

scientific article published on 06 August 2019

Expression of stress-induced MHC class I related chain molecules on human melanoma

scientific article published on 01 April 2002

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. ⬇️

scientific article published on 16 November 2017

Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

scientific article published on 12 January 2012

Genetic engineering of T cells for increased homing to the tumor site.

scientific article published on 6 November 2014

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

scientific article published on 17 August 2018

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment

scientific article published on 4 November 2015

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

scientific article

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

scientific article published on 4 September 2006

High frequency of T cells specific for cryptic epitopes in melanoma patients

scientific article published on July 2013

Identical T-cell receptor transcripts in multiple melanoma metastases

scientific article published on 01 October 2002

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

scientific article published on May 2009

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

scientific article published on 01 June 2019

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

scientific article

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

scientific article

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

scientific article published on August 2009

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

scientific article

Identification of novel survivin-derived CTL epitopes

scientific article published in February 2004

Immune-suppressive properties of the tumor microenvironment

scientific article published on 11 May 2013

Immunogenicity of Bcl-2 in patients with cancer

scientific article

Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

scientific article

Immunogenicity of constitutively active V599EBRaf

scientific article

Immunological consequences of the sentinel lymph-node biopsy--lessons from a melanoma patient

scientific article published on 01 July 2003

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue

scientific article published on 29 June 2007

Immunotherapy for metastatic colorectal cancer: present status and new options

scientific article published on 03 January 2012

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.

scientific article published on 26 December 2017

In situ cytokine therapy: redistribution of clonally expanded T cells

scientific article published on 01 January 2001

Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.

scientific article published in May 2010

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

scientific article

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

scientific article

Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.

scientific article

Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes

scientific article

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

scientific article published on 22 March 2016

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

scientific article published on 7 November 2013

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

scientific article published on 11 November 2013

Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).

scientific article

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly

scientific article

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.

scientific article published on 12 February 2009

Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion

scientific article

Mutational analysis of oncogenes and tumor suppressor genes in human cancer using denaturing gradient gel electrophoresis

scientific article published on 01 January 2002

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

scientific article (publication date: 2012)

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

scientific article

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

scientific article published on 23 December 2016

Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.

scientific article published on 26 February 2018

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

scientific article published on 15 July 2015

Regulators of apoptosis: suitable targets for immune therapy of cancer

scientific article

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

scientific article published on 22 August 2008

RhoC a new target for therapeutic vaccination against metastatic cancer

scientific article published on 16 April 2008

RhoH is important for positive thymocyte selection and T-cell receptor signaling

scientific journal article

Self-reactive T cells: suppressing the suppressors

scientific article published on 25 December 2013

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

scientific article published on 2 October 2004

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

scientific article published on March 2011

Spontaneous immunity against Bcl-xL in cancer patients

scientific article

Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease

scientific article published on 17 September 2014

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

scientific article

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

scientific article published on 30 September 2019

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

article

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients.

scientific article published on 6 November 2014

T-cell clonotypes in cancer

scientific article

T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors

scientific article published on 13 February 2014

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting

scientific article published on 29 October 2019

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

scientific article

Targetless T cells in cancer immunotherapy

scientific article published on 19 April 2016

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

scientific article

The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

scientific article published on 20 January 2016

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.

scientific article

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens ⬇️

scientific article published on August 1, 2010

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

scientific article

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

scientific article published on 7 September 2009

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

scientific article published on October 2008

The immunogenicity of the hTERT540-548 peptide in cancer

scientific article published on January 2008

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

scientific article (publication date: February 2004)

The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?

scientific article published on 01 April 2005

The universal character of the tumor-associated antigen survivin

scientific article published on October 2007

Therapeutic cancer vaccines in combination with conventional therapy

scientific article published on 29 June 2010

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

scientific article published on October 2008

Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2

scientific article published on 01 January 2016

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

scientific article published on 30 January 2015

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

scientific article published on 17 December 2011

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination

scientific article published on 17 February 2009

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

scientific article published in October 2010

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

scientific article published on 15 February 2016

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

scientific article published on 02 June 2021

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

scientific article

Paulina is supported by:

About Paulina

Help